MedTrace Logo

Predictive Factors and Consequences of Myocardial Fibrosis in Hypertrophic Cardiomyopathy

NCT02922517 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2021-09-09

No results posted yet for this study

Summary

Fibrosis, myocardial deformation and biomarkers in hypertrophic cardiomyopathy (HCM)

Conditions

Sponsors & Collaborators

  • University Hospital, Lille

    collaborator OTHER

  • Rennes University Hospital

    collaborator OTHER

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Philippe Mabo, PU-PH · Rennes University Hospital

  • Erwan Donal, McU-PH · Rennes University Hospital

  • Pascal de Groote, PH · Lille University Hospital

  • Anne-Sophie Polge, PH · Lille University Hospital

  • Marjorie Richardson, PH · Lille University Hospital

  • Nicolas Lamblin, PH · Lille University Hospital

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02922517 on ClinicalTrials.gov